Intrinsic Value of S&P & Nasdaq Contact Us

Henry Schein, Inc. HSIC NASDAQ

NASDAQ Global Select • Healthcare • Medical - Distribution • US • USD

SharesGrow Score
51/100
1/7 Pass
SharesGrow Intrinsic Value
$147.54
+91.1%
Analyst Price Target
$90.17
+16.8%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Henry Schein, Inc. (HSIC) trades at a trailing P/E of 22.1, forward P/E of 14.5. Trailing earnings yield is 4.52%, forward earnings yield 6.89%. PEG 3.07. Graham Number is $55.83.

Criteria proven by this page:

  • VALUE (48/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
  • Forward P/E 14.5 (down from trailing 22.1) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 3.07 — above 2.0 suggests expensive relative to earnings growth.
  • Trailing Earnings Yield 4.52% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 6.89% as earnings recover.
  • Analyst consensus target $90.17 (+16.8% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 51/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
51/100
SG Score
View full scorecard →
~
VALUE
48/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
46/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
53/100
→ Income
GROWTH
30/100
→ Income
INCOME
30/100
→ Income

Valuation Snapshot — HSIC

Valuation Multiples
P/E (TTM)22.1
Forward P/E14.5
PEG Ratio3.07
Forward PEG0.23
P/B Ratio2.71
P/S Ratio0.67
EV/EBITDA12.4
Per Share Data
EPS (TTM)$3.39
Forward EPS (Est.)$5.32
Book Value / Share$40.85
Revenue / Share$112.34
FCF / Share$4.78
Yields & Fair Value
Earnings Yield4.52%
Forward Earnings Yield6.89%
Dividend Yield0.00%
Graham Number$55.83
SharesGrow IV$147.54 (+91.1%)
Analyst Target$90.17 (+16.8%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 18.8 2.02 3.42 0.82 -
2017 21.6 -1.20 3.13 0.71 -
2018 17.5 0.49 3.17 0.71 -
2019 19.4 -9.74 3.29 0.99 -
2020 23.7 -1.31 2.85 0.94 -
2021 17.4 0.29 3.17 0.88 -
2022 20.2 -1.63 3.15 0.86 -
2023 23.8 -1.22 2.71 0.80 -
2024 22.9 -6.62 2.63 0.70 -
2025 23.1 3.22 2.83 0.70 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $3.12 $11.57B $506.78M 4.4%
2017 $2.57 $12.46B $406.3M 3.3%
2018 $3.49 $13.2B $535.88M 4.1%
2019 $3.40 $9.99B $520.79M 5.2%
2020 $2.80 $10.12B $403.79M 4%
2021 $4.40 $12.4B $631M 5.1%
2022 $3.91 $12.65B $538M 4.3%
2023 $3.16 $12.34B $416M 3.4%
2024 $3.05 $12.67B $390M 3.1%
2025 $3.27 $13.18B $398M 3%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $5.32 $5.27 – $5.37 $13.72B $13.67B – $13.77B 10
2027 $5.87 $5.74 – $6.08 $14.22B $14.14B – $14.31B 10
2028 $6.45 $5.77 – $6.97 $14.72B $14.7B – $14.75B 5
2029 $6.80 $6.75 – $6.85 $15.3B $15.22B – $15.39B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message